Patent details

Basic Information

Publication number:

EP3053581

PCT Application Number:

JP2014075804

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP148495955

PCT Publication Number:

WO2015046484

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

THERAPEUTIC AGENT FOR OSTEOPOROSIS

French Title of Invention:

AGENT THÉRAPEUTIQUE CONTRE L'OSTÉOPOROSE

German Title of Invention:

THERAPEUTIKUM GEGEN OSTEOPOROSE

SPC Number:

Dates

Filing date:

29/09/2014

Grant date:

12/02/2020

EP Publication Date:

10/08/2016

PCT Publication Date:

02/04/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/02/2020

EP B1 Publication Date:

12/02/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/09/2020

Expiration date:

29/09/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/02/2020

 

 

Name:

National University Corporation Tokyo University of Agriculture and Technology

Address:

3-8-1, Harumi-cho Fuchu-shi, Tokyo 183-8538, Japan (JP)

Name:

Taiho Pharmaceutical Co., Ltd.

Address:

1-27 Kandanishiki-cho, Chiyoda-ku Tokyo 101-8444, Japan (JP)

Inventor

1

Name:

INADA, Masaki

Address:

Japan (JP)

2

Name:

MIYAURA, Chisato

Address:

Japan (JP)

3

Name:

FUJITA, Hidenori

Address:

Japan (JP)

Priority

Priority Number:

201314041222

Priority Date:

30/09/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/47; A61P 19/10;

Publication

European Patent Bulletin

Issue number:

202007

Publication date:

12/02/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages